MedX Health Corp., a global leader in teledermatology and non-invasive skin analysis, announced the appointment of Dr. Symon D. Cotton, accomplished medical device innovator and co-developer of SIAscopy, as Strategic Advisor to the Company.
Dr. Cotton is an experienced author and leader in medical technology innovation, currently serving as Head of Life Sciences at a leading technology organization. His career has been defined by work at the intersection of engineering, biology and computation, where he has successfully guided numerous companies through the development of novel medical devices and digital health platforms.
Health Technology Insights: TIME Names CancerIQ as One of World’s Top HealthTech Companies
As one of the key scientific architects of Spectrophotometric Intracutaneous Analysis (SIAscopy), Dr. Cotton collaborated with Dr. Paul Matts in its early development and codification. Together, they helped establish SIAscopy as the world’s first technology to enable the simultaneous, non-invasive measurement of melanin, hemoglobin and collagen within the skin. Their work provided the foundation for SIAscopy’s clinical adoption in dermatology and its integration into MedX’s DermSecure platform.
Beyond his foundational contributions, Dr. Cotton’s expertise extends to applying AI-driven analytics to medical imaging and diagnostics, a skill set directly aligned with MedX’s strategic roadmap. His leadership in computational biology, device design, and translational medicine equips MedX to further enhance its AI models trained on SIAscopy’s uniquely rich imaging datasets, driving greater diagnostic accuracy and scalability.
Health Technology Insights: Oculis to Present Positive Phase 2 ACUITY Trial Results at ECTRIMS 2025
“I am proud to have been part of the original SIAscopy journey and excited to rejoin the field with MedX at such a pivotal moment,” said Dr. Cotton. “With AI poised to transform teledermatology, I look forward to helping MedX leverage its unmatched imaging database and DermSecure platform to improve early skin cancer detection worldwide.”
John Gevisser, CEO of MedX Health, added: “Dr. Cotton’s contribution to SIAscopy was instrumental in shaping the technology that underpins MedX’s global teledermatology platform. His expertise in medical device innovation and computational and AI strategy will help us to extend our leadership at the forefront of skin optics and machine learning, ensuring MedX solutions remain both clinically rigorous and commercially scalable.”
Health Technology Insights: XRHealth Launches XR CareCart VR Rehab Station for Clinics
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
Source – businesswire
